Drug Coverage & PBMs terms

Who decides what medicines cost and what plans cover: pharmacy benefit managers and their reform fights, and insurance coverage and prices for GLP-1 weight-loss drugs.

340B drug pricing programA federal program that makes drug makers sell outpatient drugs at discounts to safety-net hospitals and clinics, which can then bill payers at higher rates.BiosimilarA biologic medicine shown to be highly similar to an FDA-approved biologic, with no meaningful difference in safety or effect, often sold at a lower price.Brand-name drugA prescription medicine sold under the manufacturer's trademarked name, usually while patents or exclusivity block cheaper competitors.Copay accumulatorA plan policy that does not count a drug maker's copay assistance toward your deductible or out-of-pocket maximum, so your own spending builds more slowly.Copay assistance programA drug maker's coupon or card that pays part of a brand-name drug's cost for people with private insurance, but not for Medicare or Medicaid.Copay maximizerA plan program that sets a drug's copay to the full amount of manufacturer assistance available, spreading it over the year so the patient pays little.FormularyThe list of prescription drugs a health or drug plan agrees to cover, grouped into cost levels, which can change during the year.Formulary exceptionA request that a plan cover an off-list drug, lift a restriction on a covered drug, or charge a lower cost level, backed by the prescriber.Formulary tierA cost level on a plan's drug list that sets how much you pay, with cheaper drugs on lower tiers and costly ones on higher tiers.Generic drugA medicine with the same active ingredient, strength and form as a brand-name drug, sold after the brand's exclusivity ends, usually at a lower price.List priceThe price a drug maker publishes before rebates and discounts; few payers pay it in full, but it can shape what some patients owe.Mail-order pharmacyA pharmacy that ships prescriptions to your home, usually as a 90-day supply of long-term medicines, often at a lower copay than retail.Medicare drug price negotiationA program in which Medicare negotiates prices for selected high-spending drugs with their makers, with agreed prices applying to Medicare Part B and Part D.Pharmacy benefit manager (PBM)A company hired by insurers, employers and Medicare drug plans to run the prescription benefit: drug lists, pharmacy networks, claims and price negotiations.Quantity limitA plan rule capping how much of a drug it will pay for per fill or over a period, such as a set number of pills a month.Specialty drugA high-cost medicine, often injected or infused, used for complex or chronic conditions and usually needing special handling, approval and monitoring.Specialty pharmacyA pharmacy that dispenses costly, complex drugs and usually adds nurse support, shipping with temperature controls and follow-up with the patient.Drug rebateA payment from a drug maker back to a benefit manager or plan after a sale, tied to formulary placement or volume, which lowers the plan's net cost.Spread pricingA contract arrangement in which a benefit manager bills a plan more for a drug than it pays the pharmacy and keeps the difference.GLP-1 drug coverageWhether a plan pays for GLP-1 medicines such as semaglutide, which often depends on the diagnosis the drug treats, plan rules and prior authorization.